CDK Inhibitor p18INK4c Is Required for the Generation of Functional Plasma Cells
- 31 August 2002
- journal article
- Published by Elsevier BV in Immunity
- Vol. 17 (2), 179-189
- https://doi.org/10.1016/s1074-7613(02)00364-3
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNANature, 2002
- XBP1 mRNA Is Induced by ATF6 and Spliced by IRE1 in Response to ER Stress to Produce a Highly Active Transcription FactorCell, 2001
- Limited overlapping roles of P15INK4b and P18INK4c cell cycle inhibitors in proliferation and tumorigenesisThe EMBO Journal, 2000
- Cyclin D3 Compensates for Loss of Cyclin D2 in Mouse B-lymphocytes Activated via the Antigen Receptor and CD40Published by Elsevier BV ,2000
- Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B cell activation.The Journal of Experimental Medicine, 1996
- Immunological Memory and Protective Immunity: Understanding Their RelationScience, 1996
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- The Role of Interleukin-6 in Mucosal IgA Antibody Responses in VivoScience, 1994
- Impaired immune and acute-phase responses in interleukin-6-deficient miceNature, 1994
- Sites of specific B cell activation in primary and secondary responses to T cell‐dependent and T cell‐independent antigensEuropean Journal of Immunology, 1991